Psychotropic medication management in persons with co-occurring psychiatric and substance use disorders

Journal of Psychoactive Drugs

Volumn 31, Issue 1, 1999, Pages 59-70

  Sowers, Wesley ^a   Golden, Scott ^b  

^a ST FRANCIS MEDICAL CENTER   (United States)

^b ST FRANCIS MEDICAL CENTER   (United States)

Author keywords

Comorbidity; Countertransference; Diagnosis; Dual disorders; Medication; Treatment

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; CARBAMAZEPINE; LITHIUM; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRAZODONE; VALPROIC ACID; ZOLPIDEM;

ADDICTION; ALGORITHM; ANXIETY NEUROSIS; ATTITUDE; CAREGIVER; COMORBIDITY; COUNTER TRANSFERENCE; DEPRESSION; INSOMNIA; MANIC DEPRESSIVE PSYCHOSIS; MEDICAL DECISION MAKING; MENTAL DISEASE; PATIENT EDUCATION; PSYCHODYNAMICS; PSYCHOSIS; REVIEW; RISK BENEFIT ANALYSIS; SUBSTANCE ABUSE; TREATMENT PLANNING;

EID: 0033004875     PISSN: 02791072     EISSN: 21599777     Source Type: Journal    
DOI: 10.1080/02791072.1999.10471727     Document Type: Article

References (57)

1. Bowers, M B., Jr.; Mazure, C.M.; Nelson, C. & Jatlow, PI. 1990. Psychotogenic drug use and neuroleptic response. Schizophrenia Bulletin 16(1): 81-5.
2. Brady, K.T. & Sonne, S.C. 1995. The relationship between substance abuse and bipolar disorder. Journal of Clinical Psychiatry 56 (3): 19-24.
3. Brown, R.A.; Monti, P.M.; Myers, M.G.; Martin, R.A.; Rivnus, T & Dubreuil, M E. 1998 Depression among cocaine abusers in treatment: Relation to cocaine and alcohol use and treatment outcome. American Journal of Psychiatry 155 (2): 220-5.
4. Buckley, P.F. 1998. Novel antipsychotic medications and the treatment of comorbid substance abuse in schizophrenia. Journal of Substance Abuse Treatment 15 (2): 113-6.
5. Ciraulo, D.A.; Sands, B.F. & Shader, R.I. 1988. Critical review of liability for benzodiazepine abuse among alcoholics. American Journal of Psychiatry 145 (12): 1501-6.
6. Cornelius, J R.; Salloum, I.M.; Ehler, J.G.; Jarrett, P.J.; Cornelius, M.D.; Perel, J.M.; Thase, M E. & Black, A. 1997. Fluoxetine in depressed alcoholics. Archives of General Psychiatry 54:700-5.
7. Decker, K.P. & Ries, R.K. 1993. Differential diagnosis and psychopharmacology of dual disorders. Psychiatric Clinics of North America 16 (4): 703-18.
8. Dodes, L.M. 1990. Addiction, helplessness, and narcissistic rage. Psychoanalytic Quarterly LIX: 398-419.
9. Drake, R.E.; Mueser, K.T.; Clark, R.E. & Wallach, M.A. 1996. The course, treatment and outcome of substance disorder in persons with severe mental illness. American Journal of Orthopsychiatry 66 (1): 42-51.
10. DuPont, R.L. 1995. Anxiety and addiction: A clinical perspective on comorbidity. Bulletin of the Menninger Clinic 59 (2): A53-A72.
11. Fatemi, S.H.; Rapport, D.J.; Calabrese, J R. & Thuras, P 1997 Latotrigine in rapid-cycling bipolar disorder. Journal of Clinical Psychiatry 58 (12): 522-7.
12. Frances, R.J. & Borg, L. 1993. The treatment of anxiety in patients with alcoholism. Journal of Clinical Psychiatry 54 (5): 37-43.
13. Galanter, M. & Castaneda, R. 1988. Substance abuse among general psychiatric patients: Place of presentation, diagnosis, and treatment. American Journal of Drug & Alcohol Abuse 14 (2): 211-35.
14. Gastfriend, D R. 1997. Pharmacological treatment for psychiatric symptoms in addiction populations. In: N.S. Miller (Ed.) The Principles and Practice of Addictions in Psychiatry. Philadelphia: W.B. Saunders.
15. Gastfriend, D.R. 1993. Pharmacotherapy of psychiatric symptoms with comorbid chemical dependence. Journal of Addictive Diseases 12 (3): 155-70.
16. Grosch, W.N. 1994. Narcissism: shame, rage and addiction Psychiatric Quarterly 65 (1): 49-63.
17. Imhof, J.E. 1991. Countertransference issues in alcoholism and drug addiction. Psychiatric Annals 21 (5): 292-306
18. Imhof, J.; Hirsch, R. & Terenzi, R.E. 1983. Countertransferial and attitudinal considerations in the treatment of drug abuse and addiction. Journal of Addictions 18 (4): 491-510.
19. Janicak, P.G.; Davis, J.M.; Preskom, S. & Ayd, F. Jr. 1993 Principles and Practice of Psychopharmacotherapy. Baltimore: Williams and Wilkens.
20. Johnson, B. & Longo, L.P. 1998. Considerations in the physician's decision to prescribe benzodiazepines to patients with addiction Psychiatric Annals 28 (3): 160-5.
21. Kadden, R.M; Kranzler, H R. & Rounsaviile, B.J 1995 Validity of the distinction between substance-induced and independent depression and anxiety disorders. American Journal on Addictions 4 (2): 107-17.
22. Kales, A. 1990. Benzodiazepine hypnotics and insomnia Hospital Practice (Office Edition) 25 (3): 7-21.
23. Kaufman, E. 1990. Critical aspects of the psychodynamics of substance abuse and the evaluation of their application to a psychotherapeutic approach. International Journal of the Addictions 25 (2A): 97-116
24. Khantzian, E.J. 1985. The self-medication hypothesis of addictive disorders: Focus on heroin and cocaine dependence American Journal of Psychiatry 142: 1259-64.
25. Kranzler, H R.; Burleson, J.A.; DelBoca, F.K.; Babor, T.F.; Korner, P; Brown, J. & Bohn, M.J. 1994. Buspirone treatment of anxious alcoholics. Archives of General Psychiatry 51:720-31
26. Kush, F.R. & Sowers, W. 1996. Acute dually diagnosed inpatients: The use of self-report symptom severity instruments in persons with depressive disorders and cocaine dependence. Journal of Substance Abuse Treatment 14 (1): 61-6.
27. Lehman, A.F.; Myers, C.P.; Corty, E. & Thompson, J.W. 1994 Prevalence and patterns of dual diagnosis among psychiatric inpatients Comprehensive Psychiatry 35 (2): 106-12.
28. Longo, L.P. & Johnson, B. 1998. Treatment of insomnia in substance abusing patients. Psychiatric Annals 28 (3): 154-9
29. Mendelson, W.B. 1993. Insomnia and related sleep disorders Psychiatric Clinics of North America 16 (4): 841-51.
30. Miller, N.S. 1995. Pharmacological management of major comorbid psychiatric disorders in drug and alcohol addictions. Psychiatric Annals 25 (10): 621-7.
31. Miller, N.S. & Smith, D.E. 1997. The integration of pharmacotherapy and nonpharmacotherapy. Journal of Addictive Diseases 16(4): 51-64.
32. Minkoff, K. 1989. An integrated treatment model for dual diagnosis of psychosis and addiction. Hospital and Community Psychiatry 40 (10): 1031-36.
33. Mueller, T.I.; Goldenberg, I.M.; Gordon, A.L.; Keller, M.B. & Warshaw, M.G. 1996. Benzodiazepine use in anxiety disordered patients with and without a history of alcoholism. Journal of Clinical Psychiatry 57 (2): 83-9.
34. Nayak, D. 1998. In defense of polypharmacy. Psychiatric Annals 28 (4): 190-6.
35. Nierenherg, A.A.; Adler, L A, Peselow, E.; Zombcrg, G. & Rosenthal, M. 1994. Trazadone for antidepressant-associated insomnia American Journal of Psychiatry 151 (7): 1069-72.
36. Nunes, E.V.; McGrath, P.J. & Quitkin, F.M. 1995. Treating anxiety in patients with alcoholism. Journal of Clinical Psychiatry 56 (Suppl. 2): 3-8.
37. Parnno, L; Spaggian, M.C.; Boselli, M; DiGiovanni, G. & Terzano, M.G 1994. Clinical and polysomnographic effects of trazadone CR in chronic insomnia associated with dysthymia. Psychopharmacology Bulletin 116 (4): 389-95.
38. Pechter, B.M. & Miller, N.S. 1997. Psychopharmacotherapy for addictive and comorbid disorders: current studies. The integration of pharmacological and nonpharmacological treatments. Journal of Addictive Diseases 16 (4): 23-37.
39. Pollack, M.H.; Worthington, J.J.; Manfro, G.G.; Otto, M.W. & Zucker, B 1997. Abecamil for the treatment of generalized anxiety disorder: A placebo-controlled comparison of two dosage ranges of abecarnil and buspirone. Journal of Clinical Psychiatry 58 (Suppl. 11): 19-23.
40. Raskin, V.D & Miller, N.S. 1993. The epidemiology of the comorbidity of psychiatric and addictive disorders: A critical review. Journal of Addictive Diseases 12 (3): 45-57.
41. Ridgely, M.S.; Lambert, D.; Goodman, A.; Chichester, C.S. & Ralph, R. 1998. Interagency collaboration in services for people with cooccurring mental illness and substance use disorder. Psychiatric Services 49 (2): 236-8
42. Salloum, I.M.; Moss, H.B.; Daley, D C.; Cornelius, J R.; Kirisci, L. & Al-Maalous, M. 1998 Drug use problem awareness and treatment readiness in dual-diagnosis patients. American Journal on Addictions 7 (1): 35-42.
43. Salzman, C. & Freeman, S.A. 1998. Anxiety: Neurobiologic underpinnings. Psychiatric Annals 28 (3): 130-38.
44. Seppala, M 1995. Thoughts on anti-addiction drug therapy. Behavioral Health Management November/December: 23-4.
45. Siris, S.G. 1990. Pharmacological treatment of substance-abusing schizophrenia patients. Schizophrenia Bulletin 16(1): 111-22
46. Sonne, S.C.; Brady, K.T. & Morton, W.A. 1994. Substance abuse and bipolar affective disorder. Journal of Nervous and Mental Disease 182 (6): 349-52.
47. Sowers, W. 1998. Psychological and psychiatric consequences of sedatives, hypnotics and anxiolytics. In: R.Tarter; P. Ott & R Ammerman (eds.) Handbook of Substance Abuse: Neurobehavioral Pharmacology. New York: Plenum Press.
48. Sowers, W 1997. Treatment of persons with severe mental illness and substance use disorders in addiction programs Drug and Alcohol Forum 1(1): 15-21.
49. Sussman, N. 1997. Gabapentin and lamotrigine: Alternative agents for the treatment of bipolar disorder Primary Psychiatry August: 25-42.
50. Taylor, C.B. 1995. Treatment of anxiety disorders Benzodiazepines. In: A.F. Schatzberg & C.B. Hemeroff (Eds.) Textbook of Psychopharmacology, 1st Ed Washington, D C. American Psychiatric Press.
51. Tsuang, J.W.; Ho, A P.; Eckman, T A. & Shaner, A 1997. Dual diagnosis treatment for patients with schizophrenia who are substance dependent. Psychiatric Services 48 (7): 887-9.
52. Tucker, P. & Westermeyer, J. 1995. Substance abuse in patients with comorbid anxiety disorder. American Journal on Addictions 4 (3): 226-33.
53. Walker, R. 1992. Substance abuse and B-cluster disorders I: Understanding the dual diagnosis patient. Journal of Psychoactive Drugs 24(3): 223-41.
54. Westermeyer, J.; Kopka, S. & Nugent, S.1997. Course and severity of substance abuse among patients with comorbid major depression American Journal on Addictions 6 (4): 284-92.
55. Westermeyer, J.; Tucker, P. & Nugent, S. 1995. Comorbid anxiety disorder among patients with substance abuse disorders. American Journal on Addictions 4 (2): 97-106.
56. Young, N.K. & Grella, C.E. 1998. Mental health and substance abuse treatment services for dually diagnosed clients: Results of a statewide survey of county administrators. Journal of Behavioral Health Services & Research 25 (1): 83-92.
57. Zweben, J.E & Smith, D E. 1989. Considerations in using psychotropic medication with dual diagnosis patients in recovery Journal of Psychoactive Drugs 21 (2): 221-8.